Jorge Fleisher is the Director of Graduate Medical Education and Assistant Clerkship Director for Medicine. Dr. Jorge Fleisher, specializes in infectious disease in Miami, Florida. Dr. Jorge Fleisher is affiliated with multiple hospitals in the area, including Kendall Healthcare Group, Ltd.. He attended medical school at Other and graduated in 1996 having 19 years experience.

His main research interest is Infectious Disease.

Jack Chen Associate Professor and Deputy Director in Alaska State Virology Laboratory in University of Alaska Fairbanks, Alaska. He completed his Phd in 2000 from Virology, Department of Microbiology, Osaka University Medical School, Osaka, Japan. He served Editor-in-Chief in Journal of General and Molecular Virology and editors for Journal of Biology and Life Sciences, Cancer Therapy, Gene Therapy & Molecular Biology. He has specialties in Virus-host cell interaction and Virology diagnosis and reference.

His research interests are • Finding Role of tumor virus in human tumorigenesis. His research focuses on the transcriptional regulation of virus-host cell interactions of Kaposi’s sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV-1) and the role of tumor virus in tumorigenesis. • Emerging and zoonotic viral pathogens. Approximately 75% of these pathogens are diseases of animal origin (zoonotic), majorities are viruses. As a public health virology laboratory, we are developing new molecular tools for the diagnosis and reference of viral infection.

Pamuk Bilsel, Ph.D. is Chief Scientific Officer at FluGen, Inc. Prior to joining FluGen in 2008 as head of Research and Development, she was at Pharmexa-Epimmune where she served as Director of Molecular Biology and developed DNA vaccines based on cell mediated immunity against influenza and malaria. At Pentamer Pharmaceuticals, a San Diego start-up venture, she worked on subunit vaccines against respiratory syncitial virus using virus-like particle technology. Preceding that Dr. Bilsel worked at Aviron generating live attenuated influenza vaccine strains in addition to studies with the cold-adapted influenza vaccine which was eventually launched as MedImmune’s FluMist®. Dr Bilsel received her Ph.D. in Cell and Molecular Biology from the University of Nevada, Reno and did her post-doctoral training at St. Jude Children’s Research Hospital with Dr. Yoshihiro Kawaoka.

Dr. Bilsel brings nearly 15 years of corporate biotechnology and management experience in vaccine research against infectious diseases. Prior to joining FluGen, she was involved in developing DNA vaccines based on cell mediated immunity against influenza and malaria at Pharmexa-Epimmune where she served as Director of Molecular Biology.

Dr. Edmond Puca has received his PhD in University Hospital Center Mother Teresa during the period of 2010-2014. Currently, he is working as infectologue in University Hospital Center “Mother Teresa”.He is a member of Albanian Society of infectology.He is serving as an editorial member as well as reviewer for several reputed journals.

His research has included sepsis, HFRS and leptospirosis.

Dr. Zhang received her Ph.D. (Summa Cum Laude) from University of Gottingen, Germany. She has over a decade experience in infectious diseases, in particular in HIV molecular epidemiology and molecular evolution. She is an Assistant Professor of Epidemiology at University of Georgia, USA, and affiliated with Faculty of Infectious Diseases, Institute of Bioinformatics, and Biomedical and Health Sciences Institute at University of Georgia. She leads an interdisciplinary research group towards understanding pathogen diversity under various epidemiology settings. She enjoys teaching and educating next generation of critical thinkers and innovators in epidemiology.

Research Interests: • Molecular epidemiology of infectious diseases • Molecular evolution of viruses and their hosts • Comparative genomics • Computational immunology and virology

He is Pharmacologist & Clinical Scientist, (Accredited Senior Imaging Scientist). He is Director of The Medical Imaging Research Unit, University of South Wales. He is member of European Association of Thermology, Royal Society of Medicine, and Vice Chairman for The William Herschel Society, Bath.

His area of expertise is : Medical Imaging, Bone densitometry, Infrared Imaging.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). Editor in Chief of Journal of Vaccine Research and Development, Singapore.

His research interest are Viral Oncology, Tumor Liberated Protein (TLP), Emerging Viral Agents at Risk in Global Health Approaches to Early Diagnosis and Prompt Therapy

Hanna Radecka was graduated from the Department of Chemistry of Nicolaus Copernicus University in Toruń 1978. Since this year she was working as an academic teacher in the Chemistry Department of the Olsztyn University of Agriculture and Technology. She received a Ph.D. degree at this University in 1986. She was a visiting scientist at the Hokkaido University in Sapporo, Japan, in 1987-1988 and at the University of Tokyo in 1996, 1999 and 2001. In 2002 she has spend three months at Interuniversitair Micro-Elektronica Centrum (IMEC) in Leuven, Belgium. Since 1998, she is working at Department of Biosensors of IARFR PAS (www.pan.olsztyn.pl). In 2001 become assistant professor of analytical chemistry. In 2011 she received the title of professor of analytical chemistry and was nominated as the head of Laboratory of Bioelectroanalysis IARFR PAS.

Her research interest concerns the mechanism of the electrochemical signals generated at the organic/aqueous interface based on the formation of the supramolecular host-guest complexes. She applied this basic study for the developing of the sensors and biosensors, incorporated synthetic and naturally occurring receptors. Currently she is working on the development of the new biosensors for determination of: avian influenza viruses, possible biomarkers of Alzheimer’s and other neurodegenerative diseases present in human plasma, as well as new analytical tools suitable for investigation of interactions between proteins and small organic molecules – potential drugs.

Anke Huckriede is Professor of Vaccinology at the Department of Medical Microbiology, University Medical Center Groningen, The Netherlands. She received her PhD in cell biology from the University of Bielefeld, Germany. After having worked as a postdoc on mitochondrial diseases she switched to the field of vaccine development working on tumor vaccines and vaccines for viral diseases. Currently, her interest is in rational vaccine design. The mission of her group is to integrate in-depth knowledge of the relevant correlates of immune protection with recent insights in immunology, in particular in mechanisms of innate immunology, to generate vaccines which are optimally suited to induce effective immune responses. Her work on influenza vaccines makes use of systems immunology techniques and aims a.o. at developing universal influenza and stabilized influenza vaccines for patient-friendly administration.

Emanuele Montomoli is Professor on Public Health in the Department of Molecular Medicine at University of Siena in Italy. He received his BSc and MSc in Life Sciences from University of Siena in Italy in 1995 and he earned his MBiochem in 2001. He is also Chief of Scientific Office of VisMederi srl, a private enterprise involved in management and serology for clinical trials and focussed studies with human viruses for pharmaceutical companies. He is currently a partner of 2 EU-funded projects which focus on development new assays for flu vaccine evaluation and discover new adjuvants for intranasal immunization. Since 2012 he sits on a Board of ISIRV Society. Over the years, he has published almost 50 scientific papers and reviews, and written several chapters in textbooks.

His research interests is primarily in the field of influenza vaccines, and in particular in the study of correlates of protection. He is expert in development, standardization and validation of assays for antibody detection. He has conducted many clinical and laboratory research studies to evaluate immunogenicity and efficacy of traditional and new influenza vaccines. Recently he has participated in protocols for development and evaluation of new molecules as adjuvants. He has also undertook in planning and execution of European seroepidemiological studies for emerging infectious disease in collaboration with WHO Regional Office and eCDC.

Dr. Leyi Wang is a researcher in the Animal Disease Diagnostic Laboratory of Ohio Department of Agriculture. He received his DVM at Shandong Agricultural University in 2001 and his Ph.D. degree in virology at Ohio State University in 2009. Dr. Wang has conducted development of different platforms of vaccines against different viruses for over 10 years. He also develops new diagnostic assays for animal infectious diseases and conducts identification of emerging viruses including the variant porcine epidemic diarrhea virus and porcine deltacoronavirus.

Viral diagnosis, Molecular virology, Vaccine development.

Dr. Rafael Polidoro has completed his PhD at the age of 29 years from Universidade Federal de Minas Gerais. Has been awarded for his recombinant viruses vaccine protocol several times, including the Young Researcher Mercosul Award of Science and Technology in 2012. He has published 5 papers in reputed journals and has been serving as a reviewer of high quality journals.

Biochemistry and Immunology and vaccines.